A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
Public ClinicalTrials.gov record NCT03123471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in subjects with moderate to severe plaque psoriasis of the scalp. Approximately 300 subjects with moderate to severe plaque psoriasis of the scalp will be randomized 2:1 to receive either apremilast 30 mg twice daily (BID) or placebo for the first 16 weeks.
Study identification
- NCT ID
- NCT03123471
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 303 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 16, 2017 (Actual)
- Primary completion
- Aug 13, 2018 (Actual)
- Completion
- Jan 9, 2019 (Actual)
- Last update posted
- May 13, 2020
2017 – 2019
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Arkansas Clinical Trials Center, PLLC / Hull Dermatology | Rogers | Arkansas | 72758 | — |
| Tien Q. Nguyen MD Inc | Fountain Valley | California | 92708 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| San Luis Dermatology and Laser Clinic | San Luis Obispo | California | 93405 | — |
| University of Connecticut | Farmington | Connecticut | 06030 | — |
| Florida Academic Centers Research and Education | Coral Gables | Florida | 33134 | — |
| International Dermatology Research | Miami | Florida | 33144 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Dermatologic Surgery Specialists, P.C. | Macon | Georgia | 31217 | — |
| MedaPhase INC | Newnan | Georgia | 30263 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| DS Research | Louisville | Kentucky | 40202 | — |
| DS Research | Louisville | Kentucky | 40241 | — |
| Dermatology and Advanced Aesthetics | Lake Charles | Louisiana | 70605 | — |
| Lawrence Green, MD, LLC | Rockville | Maryland | 20850 | — |
| Central Dermatology | St Louis | Missouri | 63117 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Forest Hills Dermatology Group | Forest Hills | New York | 11375 | — |
| Icahn School of Medicine at Mount Sinai Medical Center | New York | New York | 10029 | — |
| Sadick Research Group | New York | New York | 10075 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27104 | — |
| Wright State Physicians | Fairborn | Ohio | 45324 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Austin Dermatology Associates | Austin | Texas | 78705 | — |
| Modern Research Associates PLLC | Dallas | Texas | 75231 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| University of Utah | Salt Lake City | Utah | 84107 | — |
| Virginia Clinical Research Inc | Norfolk | Virginia | 23502 | — |
| Eastern Virginia Medical School | Norfolk | Virginia | 23507 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03123471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03123471 live on ClinicalTrials.gov.